logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Formulating Poorly Water Soluble Drugs 2nd Edition Robert O Williams Iii

  • SKU: BELL-5696316
Formulating Poorly Water Soluble Drugs 2nd Edition Robert O Williams Iii
$ 31.00 $ 45.00 (-31%)

5.0

68 reviews

Formulating Poorly Water Soluble Drugs 2nd Edition Robert O Williams Iii instant download after payment.

Publisher: Springer International Publishing
File Extension: PDF
File size: 18.95 MB
Pages: 781
Author: Robert O. Williams III, Alan B. Watts, Dave A. Miller (eds.)
ISBN: 9783319426075, 9783319426099, 3319426079, 3319426095
Language: English
Year: 2016
Edition: 2

Product desciption

Formulating Poorly Water Soluble Drugs 2nd Edition Robert O Williams Iii by Robert O. Williams Iii, Alan B. Watts, Dave A. Miller (eds.) 9783319426075, 9783319426099, 3319426079, 3319426095 instant download after payment.

The objective of this volume is to consolidate within a single text the most current knowledge, practical methods, and regulatory considerations pertaining to formulations development with poorly water-soluble molecules. A pharmaceutical scientist’s approach toward solubility enhancement of a poorly water-soluble molecule typically includes detailed characterization of the compound’s physiochemical properties, solid-state modifications, advanced formulation design, non-conventional process technologies, advanced analytical characterization, and specialized product performance analysis techniques. The scientist must also be aware of the unique regulatory considerations pertaining to the non-conventional approaches often utilized for poorly water-soluble drugs. One faced with the challenge of developing a drug product from a poorly soluble compound must possess at minimum a working knowledge of each of the abovementioned facets and detailed knowledge of most. In light of the magnitude of the growing solubility problem to drug development, this is a significant burden especially when considering that knowledge in most of these areas is relatively new and continues to develop

Related Products